Unbound Cloxacillin Concentrations During Continuous Infusion

Launched by EMELI MÅNSSON · Feb 23, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how cloxacillin, a medicine used to treat serious infections caused by a bacteria called Staphylococcus aureus, works when given continuously through an infusion. Researchers want to measure the amount of cloxacillin in the body to make sure it is effective but not too much, which could cause side effects. They will also create a model to help doctors determine the right dosage based on individual factors like age, gender, kidney function, and protein levels in the blood.

To participate in this trial, you need to be at least 18 years old and have a doctor who plans to start you on a continuous infusion of cloxacillin. Unfortunately, if you are unable or unwilling to give written consent, you won't be able to join the study. If eligible, you can expect to be monitored closely while receiving this medication to help improve treatment for future patients with similar infections. The trial is not yet recruiting, but it aims to gather important information that could help optimize the use of cloxacillin in the hospital setting.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18 years or older
• • Treating physician has decided to start continuous infusion of cloxacillin
• Exclusion Criteria:
• • Unwilling or unable to provide written informed consent